Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury

Abstract Acute lung injury (ALI) is characterized by severe inflammation in lung tissue, excessive immune response and impaired lung function. In hospitalized high-risk patients and cases of secondary infection due to surgical contamination, it can lead to higher mortality rates and require immediat...

Full description

Saved in:
Bibliographic Details
Main Authors: Jungbum Kim, Donghyuk Seo, So-Yeol Yoo, Hye-Jin Lee, Jisun Kim, Ji Eun Yeom, Jae-Young Lee, Wooram Park, Kyung Soo Hong, Wonhwa Lee
Format: Article
Language:English
Published: SpringerOpen 2025-02-01
Series:Nano Convergence
Subjects:
Online Access:https://doi.org/10.1186/s40580-025-00475-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861725708943360
author Jungbum Kim
Donghyuk Seo
So-Yeol Yoo
Hye-Jin Lee
Jisun Kim
Ji Eun Yeom
Jae-Young Lee
Wooram Park
Kyung Soo Hong
Wonhwa Lee
author_facet Jungbum Kim
Donghyuk Seo
So-Yeol Yoo
Hye-Jin Lee
Jisun Kim
Ji Eun Yeom
Jae-Young Lee
Wooram Park
Kyung Soo Hong
Wonhwa Lee
author_sort Jungbum Kim
collection DOAJ
description Abstract Acute lung injury (ALI) is characterized by severe inflammation in lung tissue, excessive immune response and impaired lung function. In hospitalized high-risk patients and cases of secondary infection due to surgical contamination, it can lead to higher mortality rates and require immediate intervention. Currently, clinical treatments are limited in symptomatic therapy as mechanical ventilation and corticosteroids, having insufficient efficacy in mitigating the cause of progression to severe illness. Here we report a pulmonary targeting lung-homing nanoliposome (LHN) designed to attenuate excessive Neutrophil Extracellular Trap formation (NETosis) through sivelestat and DNase-1, coupled with an anti-inflammatory effect mediated by 25-hydroxycholesterol (25-HC), offering a promising intervention for the acute phase of ALI. Through intratracheal delivery, we intend prompt and constant action within the lungs to effectively prevent excessive NETosis. Isolated neutrophils from blood samples of severe ARDS patients demonstrated significant anti-NETosis effects, as well as reduced proinflammatory cytokine secretion. Furthermore, in a murine model of LPS-induced ALI, we confirmed improvements in lung histopathology, and early respiratory function. Also, attenuation of systemic inflammatory response syndrome (SIRS), with notable reductions in NETosis and neutrophil trafficking was investigated. This presents a targeted therapeutic approach that can be applied in early stages of high-risk patients to prevent severe pulmonary disease progression.
format Article
id doaj-art-6a6a82b744cf410ba3b86c70d6d6208e
institution Kabale University
issn 2196-5404
language English
publishDate 2025-02-01
publisher SpringerOpen
record_format Article
series Nano Convergence
spelling doaj-art-6a6a82b744cf410ba3b86c70d6d6208e2025-02-09T12:49:49ZengSpringerOpenNano Convergence2196-54042025-02-0112111710.1186/s40580-025-00475-4Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injuryJungbum Kim0Donghyuk Seo1So-Yeol Yoo2Hye-Jin Lee3Jisun Kim4Ji Eun Yeom5Jae-Young Lee6Wooram Park7Kyung Soo Hong8Wonhwa Lee9Department of Chemistry, Sungkyunkwan UniversityDepartment of Chemistry, Sungkyunkwan UniversityCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversityDepartment of Chemistry, Sungkyunkwan UniversityDepartment of Chemistry, Sungkyunkwan UniversityDepartment of Chemistry, Sungkyunkwan UniversityCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversityDepartment of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan UniversityDivision of Pulmonology and Allergy, Department of Internal Medicine, College of Medicine, Regional Center for Respiratory Diseases, Yeungnam University, Yeungnam University Medical CenterDepartment of Chemistry, Sungkyunkwan UniversityAbstract Acute lung injury (ALI) is characterized by severe inflammation in lung tissue, excessive immune response and impaired lung function. In hospitalized high-risk patients and cases of secondary infection due to surgical contamination, it can lead to higher mortality rates and require immediate intervention. Currently, clinical treatments are limited in symptomatic therapy as mechanical ventilation and corticosteroids, having insufficient efficacy in mitigating the cause of progression to severe illness. Here we report a pulmonary targeting lung-homing nanoliposome (LHN) designed to attenuate excessive Neutrophil Extracellular Trap formation (NETosis) through sivelestat and DNase-1, coupled with an anti-inflammatory effect mediated by 25-hydroxycholesterol (25-HC), offering a promising intervention for the acute phase of ALI. Through intratracheal delivery, we intend prompt and constant action within the lungs to effectively prevent excessive NETosis. Isolated neutrophils from blood samples of severe ARDS patients demonstrated significant anti-NETosis effects, as well as reduced proinflammatory cytokine secretion. Furthermore, in a murine model of LPS-induced ALI, we confirmed improvements in lung histopathology, and early respiratory function. Also, attenuation of systemic inflammatory response syndrome (SIRS), with notable reductions in NETosis and neutrophil trafficking was investigated. This presents a targeted therapeutic approach that can be applied in early stages of high-risk patients to prevent severe pulmonary disease progression.https://doi.org/10.1186/s40580-025-00475-4Lung-homing nanoliposomeNETosisAcute respiratory distress syndrome (ARDS)DNase-1Sivelestat
spellingShingle Jungbum Kim
Donghyuk Seo
So-Yeol Yoo
Hye-Jin Lee
Jisun Kim
Ji Eun Yeom
Jae-Young Lee
Wooram Park
Kyung Soo Hong
Wonhwa Lee
Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
Nano Convergence
Lung-homing nanoliposome
NETosis
Acute respiratory distress syndrome (ARDS)
DNase-1
Sivelestat
title Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
title_full Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
title_fullStr Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
title_full_unstemmed Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
title_short Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
title_sort lung homing nanoliposomes for early intervention in netosis and inflammation during acute lung injury
topic Lung-homing nanoliposome
NETosis
Acute respiratory distress syndrome (ARDS)
DNase-1
Sivelestat
url https://doi.org/10.1186/s40580-025-00475-4
work_keys_str_mv AT jungbumkim lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT donghyukseo lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT soyeolyoo lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT hyejinlee lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT jisunkim lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT jieunyeom lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT jaeyounglee lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT woorampark lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT kyungsoohong lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury
AT wonhwalee lunghomingnanoliposomesforearlyinterventioninnetosisandinflammationduringacutelunginjury